These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 2856350)

  • 1. Current issues in blood component therapy: transmission of infectious diseases.
    Menitove JE
    Oncology (Williston Park); 1987 Jun; 1(4):21-30. PubMed ID: 2856350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-associated hepatitis and AIDS. What is the risk?
    Bove JR
    N Engl J Med; 1987 Jul; 317(4):242-5. PubMed ID: 3110619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of mandatory transmissible diseases screening in Indian blood donors.
    Choudhury N; Ramesh V; Saraswat S; Naik S
    Indian J Med Res; 1995 Jun; 101():229-32. PubMed ID: 7672831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of transfusion associated infections in multitransfused children in relation to mandatory screening of HIV in donated blood.
    Aggarwal V; Prakash C; Yadav S; Chattopadhya D
    Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):699-706. PubMed ID: 9656388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis A, B, CMV, EBV and HIV infections in premature and term newborn infants following polytransfusion].
    Keller KM; Bambauer C; Wirth S; Queisser-Luft A; Falke D; Baumann W
    Monatsschr Kinderheilkd; 1990 Sep; 138(9):611-4. PubMed ID: 2172805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of transfusion transmitted diseases in renal transplant recipients.
    Choudhury N; Naik S; Sharma RK; Elhence P; Ramesh V; Gupta RK
    Indian J Pathol Microbiol; 1996 Jul; 39(3):191-5. PubMed ID: 8972147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transfusion safety].
    Aprili G
    Haematologica; 1991 Jun; 76 Suppl 3():385-94. PubMed ID: 1752537
    [No Abstract]   [Full Text] [Related]  

  • 9. Transfusion-dependent thalassemia: viral complications (epidemiology and follow-up).
    de Montalembert M; Girot R; Mattlinger B; Lefrère JJ
    Semin Hematol; 1995 Oct; 32(4):280-7. PubMed ID: 8560285
    [No Abstract]   [Full Text] [Related]  

  • 10. [Transfusion-induced virus infections: how great is the risk?].
    Sibrowski W; Penner M; Kühnl P
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():4-9. PubMed ID: 8374287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The problem of post-transfusion hepatitis].
    Sugg M
    Beitr Infusionther Klin Ernahr; 1986; 15():30-8. PubMed ID: 3019299
    [No Abstract]   [Full Text] [Related]  

  • 12. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-transmitted hepatitis virus infection.
    Dodd RY
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):137-54. PubMed ID: 7737938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-transmitted viruses.
    Wright-Kanuth MS; Smith LA
    Clin Lab Sci; 2003; 16(4):221-9. PubMed ID: 14626440
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of the Ministry of Health in the prevention of diseases caused by blood transfusion].
    Wolpert Barraza E; Córdova MS; Robles Díaz G; Reyes López PA
    Gac Med Mex; 1994; 130(6):412-24. PubMed ID: 7557054
    [No Abstract]   [Full Text] [Related]  

  • 17. [Expanded serologic infection testing of autologous blood donors: a report of experiences].
    Zimmermann R; Weisbach V; Wittmann G; Zingsem J; Neidhardt B; Eckstein R
    Beitr Infusionsther Transfusionsmed; 1996; 33():196-200. PubMed ID: 8974693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Viral safety of blood and blood products].
    Gürtler L
    Fortschr Med; 1993 Nov; 111(33):526-7. PubMed ID: 8307536
    [No Abstract]   [Full Text] [Related]  

  • 19. Patients, needles, and healthcare workers: understanding the epidemiology, pathophysiology, and transmission of the human immunodeficiency virus, hepatitis B and C, and cytomegalovirus.
    Hibberd PL
    J Intraven Nurs; 1995; 18(6 Suppl):S22-31. PubMed ID: 8714928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
    Meili EO
    Beitr Infusionsther; 1989; 24():46-55. PubMed ID: 2481548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.